As a treatment of hypercholesterolemia, simvastatin competitively binds to HMG-coenzyme A with HMGR (Maciejak et al., 2013), reducing the synthesis of cholesterol (or ergosterol in yeast). This evidence concerns the gene HMGA1 and familial hypercholesterolemia.